Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
32892 | 101 | 38.0 | 74% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SPHAEROPHYSA SALSULA | Author keyword | 11 | 69% | 9% | 9 |
2 | ANTIQUAILLE HOSP | Address | 1 | 50% | 1% | 1 |
3 | CELLULAR REDOX REGULATION | Author keyword | 1 | 50% | 1% | 1 |
4 | DIABETIC NEPHROPATHY PREVENTION | Author keyword | 1 | 50% | 1% | 1 |
5 | MESANGIAL CELLS RAT | Author keyword | 1 | 50% | 1% | 1 |
6 | RAT AGE | Author keyword | 1 | 50% | 1% | 1 |
7 | ENVIRONM HYG PARASITOL | Address | 0 | 33% | 1% | 1 |
8 | INTRACELLULAR SIGNALLING PEPTIDES AND PROTEINS | Author keyword | 0 | 33% | 1% | 1 |
9 | PATHOL SOSNOWIEC | Address | 0 | 33% | 1% | 1 |
10 | UNITE RECH PHYSIOPATHOL CARDIOVASC | Address | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SODIUM SELENATE | 11 | 40% | 21% | 21 |
2 | DBDB MICE | 1 | 100% | 2% | 2 |
3 | MITOCHONDRIAL FAILURE | 1 | 50% | 1% | 1 |
4 | CYCLOARTANE | 0 | 11% | 2% | 2 |
5 | RENAL CORTICAL TUBULES | 0 | 17% | 1% | 1 |
6 | FATTY ACID DISTRIBUTION | 0 | 10% | 1% | 1 |
7 | 9 10 SECO CYCLOARTANES | 0 | 100% | 1% | 1 |
8 | DIABETIC DBDB MICE | 0 | 100% | 1% | 1 |
9 | SPHAEROPHYSA SALSULA | 0 | 100% | 1% | 1 |
10 | VANADATE INDUCTION | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of Antioxidants in Redox Regulation of Diabetic Cardiovascular Complications | 2010 | 18 | 158 | 9% |
Selenium: an insulin-mimetic | 2000 | 98 | 50 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTIQUAILLE HOSP | 1 | 50% | 1.0% | 1 |
2 | ENVIRONM HYG PARASITOL | 0 | 33% | 1.0% | 1 |
3 | PATHOL SOSNOWIEC | 0 | 33% | 1.0% | 1 |
4 | UNITE RECH PHYSIOPATHOL CARDIOVASC | 0 | 33% | 1.0% | 1 |
5 | WELLBEING PROD | 0 | 33% | 1.0% | 1 |
6 | IST ONCOL MOL | 0 | 25% | 1.0% | 1 |
7 | PHYSIOL BIOPHYS INTERNAL MED | 0 | 25% | 1.0% | 1 |
8 | RAIC | 0 | 25% | 1.0% | 1 |
9 | INT HLTH NUTR | 0 | 17% | 1.0% | 1 |
10 | KOREA FDA | 0 | 17% | 1.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000223798 | SERUM SELENIUM//SELENIUM STATUS//SELENIUM INTAKE |
2 | 0.0000174247 | SELENOPROTEIN//SELENOCYSTEINE//SELENOPROTEIN W |
3 | 0.0000169410 | ADVANCED OXIDATION PROTEIN PRODUCTS//ADVANCED OXIDATION PROTEIN PRODUCTS AOPP//AOPP |
4 | 0.0000120557 | VANADATE//VANADYL SULFATE//CATEDRA BIOQUIM PATOL |
5 | 0.0000119902 | ANALYT BIOINORGAN CHEM//INORGANIC MEDICINE//BLOOD GLUCOSE NORMALIZING EFFECT |
6 | 0.0000102321 | METHYLSELENINIC ACID//SELENIUM BINDING PROTEIN 1//SELENIUM BINDING PROTEIN |
7 | 0.0000095236 | DIABETIC CARDIOMYOPATHY//DIABETIC HEART//ENVIRONM OCCUPAT AGR HLTH |
8 | 0.0000076671 | RHEUMATOL CONNECT TISSUE//COMMON RECEPTOR CHAIN//HLTH SCI B115 |
9 | 0.0000074651 | ADENYLYL CYCLASE SYSTEM//ADENYLYL CYCLASE MECHANISM//INSULIN SUPERFAMILY PEPTIDES |
10 | 0.0000072355 | LABISIA PUMILA//HALIA BARA//PHALERIA MACROCARPA |